Exin Therapeutics
AI drug discovery platform for neurotherapeutics
Exin Therapeutics is active in the healthcare space based in San Francisco, CA, USA.
Profile
We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house.
We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-Neuralink), EPFL, Meta, and UCL.
In 1.5 months since landing in SF, we went from nothing to (1) opening and operating an animal lab in South SF, (2) obtaining a proof-of-concept in mice, (3) building a multimodal AI model that directs our screening approach and (4) submitting two provisional patents; all while utilizing less than 50% of our YC funding.
Exin Therapeutics is positioned in healthcare, a segment that rewards a clear, focused offering.
San Francisco, CA, USA is where the company is located.
It is recorded at the Winter 2025 stage.
Recorded headcount: 9 employees.
Directory analysis
Exin Therapeutics is a San Francisco‑based biotech that builds an AI‑driven drug discovery platform for neurotherapeutics. The company combines machine‑learning models with high‑throughput mouse studies to identify compounds that modulate neural activity, initially targeting epilepsies associated with autism and Parkinson’s disease. Early proof‑of‑concept results and a multidisciplinary advisory board support its R&D efforts.
Positioning: Operating in the competitive neuropharma sector, Exin leverages AI and in‑house animal data to accelerate lead discovery. Its focus on rare neurological disorders could carve out a niche in a crowded therapeutic landscape.
Note: Exin’s AI platform is aimed at discovering drugs that modulate brain activity.
Auto-generated directory analysis from public data · updated 9 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 9 |
| Stage | Winter 2025 |
Website: www.exintherapeutics.com
Browse related
Create a free account